Thanks Kirkers, The news part is interesting: Anteo Diagnostics' (ASX: ADO) shares firmed another 11.8% yesterday to close the trading day at $0.19, on strong volume of 8.5 million shares.
Anteo's shares have now doubled since mid-November, with the stock enjoying a re-rating in the biotechnology sector.
The company has a unique focus in being a surface coating company with its proprietary family of enabling chemistries (known as Mix&Go) enabling production of surfaces for the biotechnology, diagnostics and pharmaceutical industries.
Adding further to the Anteo story, the company recently signed a Heads of Terms with BBI Solutions, an immunoassay development and manufacturing services company.
Anteo and BBI to collaborate on a project investigating the manufacturing and performance benefits of Mix&Go™ on BBI particles
ADO Price at posting:
18.2¢ Sentiment: Hold Disclosure: Held
